2026 ICD-10-CM Diagnosis Code G13.0Paraneoplastic neuromyopathy and neuropathy
ICD-10-CM Codes›G00–G99›G10-G14›G13
- Billable — Valid for Submission
- Chronic Condition
G13.0 is a billable ICD-10-CM diagnosis code for paraneoplastic neuromyopathy and neuropathy. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is a manifestation code that cannot be reported as the principal diagnosis. Coders also document this condition as neuropathy associated with dysproteinemias. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other nervous system disorders (neither hereditary nor degenerative).
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for G13.0.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Neuropathy associated with dysproteinemias
- Neuropathy due to multiple myeloma
- Paraneoplastic neuropathy
- Paraneoplastic peripheral neuropathy
- Paraneoplastic sensorimotor neuropathy
- Paraneoplastic sensory neuropathy
- Plasma cell dyscrasia with polyneuropathy
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Carcinomatous neuromyopathy
- Sensorial paraneoplastic neuropathy Denny Brown
Code First
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Brain Diseases
Your brain is the control center of your body. It controls your thoughts, memory, speech, and movement. It regulates the function of many organs. It's part of your nervous system, which also includes your spinal cord and peripheral nerves. The nervous system sends signals between your brain and the rest of the body.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert G13.0 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About G13.0Overview
Is G13.0 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report paraneoplastic neuromyopathy and neuropathy on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Can G13.0 be a principal diagnosis?
No. This is a manifestation code: paraneoplastic neuromyopathy and neuropathy describes the manifestation of an underlying disease rather than the disease itself, so the underlying condition is sequenced first.
What is the ICD-9 equivalent of G13.0?
Under the General Equivalence Mappings, paraneoplastic neuromyopathy and neuropathy converts to ICD-9-CM 357.3 (neuropathy in malig dis). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
